ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : National Institutes of Health : National Institute of Allergy and Infectious Diseases (NIAID)


Include trials that are no longer recruiting patients.

962 studies were found. Here are studies 1 to 50.
1.CompletedA "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Condition: HIV Infections
2.Completed(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections
3.RecruitingAcetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases
4.RecruitingActivation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia
Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
5.CompletedActive Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Condition: HIV Infections
6.CompletedActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy
7.CompletedActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity
8.TerminatedActive Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity
9.No longer recruitingAdding New Drugs for HIV Infected Patients Failing Current Therapy
Condition: HIV Infections
10.CompletedAddition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Condition: HIV Infections
11.TerminatedThe Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
Condition: HIV Infections
12.CompletedAdefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
Conditions: Hepatitis B; HIV Infection
13.No longer recruitingAdministration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
Condition: HIV Infections
14.CompletedAerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
15.CompletedAerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
16.CompletedAllopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Condition: Leishmaniasis
17.RecruitingAlternative Dosing Strategy for Anti-HIV Drugs
Condition: HIV Infections
18.No longer recruitingALVAC-HIV vCP1452 Alone and Combined with MN rgp120
Conditions: HIV Infections; HIV Seronegativity
19.CompletedAnalysis of Bronchial Tissue and Fluid in Patients with Wegener's Granulomatosis
Conditions: Inflammation; Vasculitis; Wegener's Granulomatosis
20.RecruitingAnalysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy
Condition: HIV Infection
21.No longer recruitingAnalysis of Immune Responses to HIV Vaccines
Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
22.RecruitingAnti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
23.RecruitingAnti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
Condition: HIV Infections
24.RecruitingAnti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents
Condition: HIV Infections
25.RecruitingAnti-HIV Drugs During Pregnancy
Condition: HIV Infections
26.RecruitingAnti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
Conditions: HIV Infections; Tuberculosis
27.CompletedThe Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year
Condition: HIV Infections
28.CompletedAnti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Conditions: Acquired Immunodeficiency Syndrome; Disease Transmission, Vertical; HIV Infections
29.Not yet recruitingAnti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
Condition: HIV Infections
30.CompletedAnti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
31.No longer recruitingAntibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections
32.CompletedAntibody and Delayed Cyclosporine versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
Conditions: Kidney Transplantation; Chronic Allograft Nephropathy
33.CompletedAntiviral Activity of and Resistance to Lamivudine in Combination with Zidovudine, Stavudine, or Didanosine
Condition: HIV Infections
34.RecruitingApheresis Procedures for Research Studies
Condition: Blood Component Removal
35.RecruitingApheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Conditions: Leukopheresis; Plasmapheresis
36.CompletedAPSV in vaccinia naive adults
Condition: Smallpox
37.CompletedAssessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness
Conditions: Atherosclerosis; Myocardial Infarction
38.No longer recruitingAssessment of dryvax in previously vaccinated adults
Condition: Smallpox
39.CompletedAssessment of Lung Inflammation in Patients with Atopic Asthma Using Positron Emission Tomography
Conditions: Asthma; Hypersensitivity; Lung Diseases; Wegener's Granulomatosis
40.RecruitingAssessment of oral acyclovir in neonates with HSV involving the CNS
Condition: Herpes Simplex
41.RecruitingAssessment of pleconaril for treatment of enteroviral sepsis syndrome in neonates
Condition: Sepsis
42.CompletedAn Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients
Condition: HIV Infections
43.RecruitingAssessment of valganciclovir in neonates with CMV
Condition: Cytomegalovirus Infections
44.RecruitingAtazanavir Used in Combination with Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Condition: HIV Infections
45.RecruitingAtazanavir/Ritonavir Maintenance Therapy
Condition: HIV Infections
46.Not yet recruitingAtorvastatin Therapy in Patients with Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Conditions: Multiple Sclerosis; Clinically Isolated Syndrome
47.RecruitingAzithromycin/Bicillin for treatment of early syphilis
Condition: Syphilis
48.RecruitingThe Biology of HIV Transmission
Condition: HIV Infections
49.CompletedBlood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis; Anaphylaxis
50.CompletedBlood Levels of Abacavir after One Dose in HIV-Infected Children and Adolescents
Condition: HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act